Emerging evidence has indicated that ARHGAP10 inhibited proliferation and migration of lung cancer [19], but the biological process and potential mechanism of ARHGAP10 in NSCLC epithelial–mesenchymal transition has not been previously verified. Here, ARHGAP10 is linked to lung carcinoma.